Reducing pneumococcal risk in people aged 65 years and over
File version
Version of Record (VoR)
Author(s)
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
Disease due to pneumococcus (Streptococcus pneumoniae) remains a major source of illness in older people. Conjugated pneumococcal vaccines are used extensively in national paediatric programs, whereas a 23-valent polysaccharide vaccine is mainly used in older people and high-risk groups. Data from the Netherlands have led to licensing of a conjugated pneumococcal vaccine for older people in Australia. This review examines current recommendations on pneumococcal vaccines.
Journal Title
Medicine Today
Conference Title
Book Title
Edition
Volume
20
Issue
2 Suppl
Thesis Type
Degree Program
School
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2019 Medicine Today Pty. Ltd.. Reproduced in accordance with the copyright policy of the publisher. Use hypertext link for access to the publisher's website.
Item Access Status
Note
Access the data
Related item(s)
Subject
Biomedical and clinical sciences
Clinical sciences
Persistent link to this record
Citation
Van Buynder, P, Reducing pneumococcal risk in people aged 65 years and over, Medicine Today, 2019, 20 (2 Suppl), pp. 11-14